Bristol Myers Squibb (CELG-RI) Inventory Average (2009 - 2026)

Bristol Myers Squibb has disclosed Inventory Average across 17 years of filings, most recently posting $2.7 billion for Q1 2026.

• In Q1 2026, Inventory Average rose 4.27% year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $2.7 billion (up 4.27% YoY), while the FY2025 annual figure was $2.6 billion, up 0.54% from the prior year.
• Inventory Average steadied at $2.7 billion in Q1 2026, from $2.7 billion in the prior quarter.
• Over the last five years, Inventory Average for CELG-RI reached as high as $3.2 billion in Q3 2024 and fell as low as $2.1 billion in Q1 2022.
• The 5-year median for Inventory Average is $2.6 billion (2025), against an average of $2.6 billion.
• Annual changes were most pronounced in 2024 — Inventory Average jumped 33.52% — and 2025, when it decreased 14.26%.
• A 5-year view of Inventory Average shows it stood at $2.2 billion in 2022, then climbed by 15.52% to $2.5 billion in 2023, then increased by 15.52% to $2.9 billion in 2024, then fell by 7.49% to $2.7 billion in 2025, then decreased by 0.04% to $2.7 billion in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $2.7 billion, $2.7 billion, and $2.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.